Xiaflex 0.9 MG vials
Ended Awarded
- Contract number
- SPE2DB25FD4XV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,454
Award facts
- Contract value 100% obligated
- $16,454.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,454.48 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Xiaflex 0.9 mg vials on September 15, 2025, with an ultimate completion date of October 6, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without any set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide.
Xiaflex is a prescription pharmaceutical used primarily for treating Dupuytren's contracture, a progressive hand condition. The delivery order fulfills DLA's need for this specialized injectable medication as part of its ongoing pharmaceutical supply operations supporting Department of Defense healthcare sites across the United States and globally. DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, demonstrated through its consistent contract awards for medications including Botox, Tecentriq, and various biologics, positions it well to reliably deliver this pharmaceutical product to military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FD4XV?
SPE2DB25FD4XV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FD4XV worth?
The government has obligated $16,454 on SPE2DB25FD4XV.
Is contract SPE2DB25FD4XV an order under another contract?
Yes. SPE2DB25FD4XV is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB25FD4XV competed?
The extent of competition for SPE2DB25FD4XV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award